Should I prescribe amoxicillin‑clavulanate (Augmentin) or cefdinir for a child with acute otitis media and bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Use Augmentin (Amoxicillin-Clavulanate) for This Child

For a child with acute otitis media and concurrent conjunctivitis, you should prescribe high-dose amoxicillin-clavulanate (Augmentin) at 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses. This is the explicit first-line recommendation from the American Academy of Pediatrics guidelines for this specific clinical scenario 1.

Why Augmentin Over Cefdinir

The presence of concurrent purulent conjunctivitis is a key clinical indicator that changes your antibiotic selection. This combination—known as "otitis-conjunctivitis syndrome"—signals likely infection with β-lactamase-producing Haemophilus influenzae or Moraxella catarrhalis, both of which are resistant to amoxicillin alone but covered by amoxicillin-clavulanate 1.

The Evidence Hierarchy

The AAP guidelines explicitly state that children with concurrent conjunctivitis should be initiated on high-dose amoxicillin-clavulanate rather than plain amoxicillin 1. Cefdinir is listed as an alternative treatment for penicillin allergy, not as first-line therapy for this presentation 1.

Clinical Efficacy Data

Research directly comparing these agents supports the guideline recommendation:

  • Amoxicillin-clavulanate demonstrated 86.5% clinical cure rates versus 71.0% for cefdinir in children 6-24 months with AOM (p = 0.001) 2
  • Cefdinir showed decreasing efficacy as children increased in age between 6-24 months, while amoxicillin-clavulanate maintained stable cure rates across all ages 2
  • Amoxicillin-clavulanate achieved 96% eradication of S. pneumoniae from middle ear fluid 1
  • Amoxicillin-clavulanate was more effective at eradicating Streptococcus pneumoniae compared to cefdinir 3

Dosing Specifics

Use the 14:1 ratio formulation (amoxicillin to clavulanate), which causes less diarrhea than other preparations 1. This translates to:

  • 90 mg/kg/day of amoxicillin component
  • 6.4 mg/kg/day of clavulanate component
  • Given in 2 divided doses
  • Duration: 10 days for children under 2 years; 5-7 days for children 2 years and older

Important Caveats

Adverse Effects Trade-off

Amoxicillin-clavulanate has a higher incidence of diarrhea (18.9%) compared to cefdinir (13.0%) 4. However, this increased gastrointestinal side effect burden is justified by the superior clinical efficacy in this specific scenario. The NNTH (number needed to treat for harm) is 14 for any adverse event with antibiotics versus placebo 5.

When Cefdinir Would Be Appropriate

Reserve cefdinir (14 mg/kg/day in 1-2 doses) for:

  • True penicillin allergy (not just intolerance) 1, 6
  • The chemical structure of cefdinir makes cross-reactivity with penicillin highly unlikely 1
  • Note that historical cross-reactivity rates (~10%) were overestimated; actual risk with third-generation cephalosporins is negligible 1

Reassessment Protocol

Reassess at 48-72 hours if symptoms worsen or fail to improve 1. If treatment fails:

  • Consider tympanocentesis if skilled
  • Switch to ceftriaxone (50 mg/kg IM/IV for 3 days) 1

The Microbiologic Rationale

The otitis-conjunctivitis syndrome strongly suggests β-lactamase-producing organisms. Current data show that 58-82% of H. influenzae isolates produce β-lactamase, making them resistant to amoxicillin alone 1. The clavulanate component specifically inhibits β-lactamase enzymes, restoring amoxicillin's effectiveness against these resistant strains.

Bottom line: The concurrent conjunctivitis makes this decision straightforward—use Augmentin, not cefdinir 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.